European Journal of Surgical Oncology
Volume 35, Issue 10 , Pages 1055-1059 , October 2009

Follow-up for screen-detected ductal carcinoma in situ: Results of a survey of UK centres participating in the Sloane project

  • A.J. Maxwell

      Affiliations

    • Bolton Breast Unit, Royal Bolton Hospital, Minerva Road, Bolton BL4 0JR, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 (0)1204 390046; fax: +44 (0)1204 390085.
    • ,
  • A.J. Evans

      Affiliations

    • Nottingham Breast Institute, City Hospital, Nottingham NG5 1PB, UK
    • ,
  • R. Carpenter

      Affiliations

    • St Bartholomew's Hospital, London EC1A 7BE, UK
    • ,
  • H.M. Dobson

      Affiliations

    • West of Scotland Breast Screening Centre, Glasgow G2 1QT, UK
    • ,
  • O. Kearins

      Affiliations

    • West Midlands Cancer Intelligence Unit, The University of Birmingham, Birmingham B15 2TT, UK
    • ,
  • K. Clements

      Affiliations

    • West Midlands Cancer Intelligence Unit, The University of Birmingham, Birmingham B15 2TT, UK
    • ,
  • G. Lawrence

      Affiliations

    • West Midlands Cancer Intelligence Unit, The University of Birmingham, Birmingham B15 2TT, UK
    • ,
  • H.M. Bishop

      Affiliations

    • Bolton Breast Unit, Royal Bolton Hospital, Minerva Road, Bolton BL4 0JR, UK

,Accepted 1 April 2009.

References 

  1. The Sloane Project. <http://www.sloaneproject.co.uk>.
  2. Association of Breast Surgery @ BASO . Guidelines for the management of symptomatic breast disease. Eur J Surg Oncol. 2005;31:S1–S21
  3. Scottish Intercollegiate Guidelines Network . Guideline 84: management of breast cancer in women. 2005;<www.sign.ac.uk/pdf/sign84.pdf>
  4. Royal College of Radiologists . Guidance on screening and symptomatic breast imaging. 2003;<www.rcr.ac.uk/publications.aspx?PageID=310&PublicationID=184>
  5. National Institute of Health and Clinical Excellence . Early and locally advanced breast cancer: diagnosis and treatment. 2009;<www.nice.org.uk/nicemedia/pdf/CG80FullGuideline.pdf>
  6. Rutgers EJT for the EUSOMA consensus group . Quality control in the locoregional treatment of breast cancer. Eur J Cancer. 2001;37:447–453
  7. European Society for Medical Oncology . ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of primary breast cancer. Ann Oncol. 2005;16(Suppl. 1):i7–i9
  8. National Comprehensive Cancer Network . Clinical practice guidelines in oncology: breast cancer. Version 2. 2008;<www.nccn.org/professionals/physician_gls/PDF/breast.pdf>
  9. Temple LKF, Wang EEL, McLeod RS. Preventive health care, 1999 update: 3. Follow-up after breast cancer. CMAJ. 1999;161:1001–1008
  10. Khatcheressian JL, Wolff AC, Smith TJ, et al. American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol. 2006;24:5091–5097
  11. Clinical practice guidelines for the management of early breast cancer. 2nd ed.. Camperdown, NSW, Australia: National Breast Cancer Centre; 2001;
  12. The clinical management of ductal carcinoma in situ, lobular carcinoma in situ and atypical hyperplasia of the breast. 1st ed.. Camperdown, NSW, Australia: National Breast Cancer Centre; 2003;
  13. Morrow M, Strom EA, Bassett LW, et al. Standard for the management of ductal carcinoma in situ of the breast (DCIS). CA Cancer J Clin. 2002;52:256–276
  14. Liberman L, Van Zee KJ, Dershaw DD, et al. Mammographic features of local recurrence in women who have undergone breast-conserving therapy for ductal carcinoma in situ. AJR Am J Roentgenol. 1997;168:489–493
  15. Pinsky RW, Rebner M, Pierce LJ, et al. Recurrent cancer after breast-conserving surgery with radiation therapy for ductal carcinoma in situ: mammographic features, method of detection, and stage of recurrence. AJR Am J Roentgenol. 2007;189:140–144

PII: S0748-7983(09)00121-8

doi: 10.1016/j.ejso.2009.04.002

European Journal of Surgical Oncology
Volume 35, Issue 10 , Pages 1055-1059 , October 2009

Article Tools